Richmond Pharmacology to provide Immediate Life Support (ILS) Courses
Posted:
31
July 2019
In line with our on-going commitment to providing quality training and promoting the highest safety standard, Richmond Pharmacology are pleased to announce that our ILS
Richmond Pharmacology to provide Immediate Life Support (ILS) Courses
In line with our on-going commitment to providing quality training and promoting the highest safety standard, Richmond Pharmacology are pleased to announce that our ILS Courses are now open to the public. In association with the Resuscitation Council UK, Richmond Pharmacology’s highly trained Resuscitation and Clinical Skills Practitioners will equip external healthcare professionals with the skills to assist patients in preventing or treating cardiac arrest.
To register your interest, or to find out more about the training offered by Richmond Pharmacology, please click here.Additionally, to find out more about the ILS training courses offered by the Resuscitation Council (UK), please check here.
Participant-Centred Recruitment and Retention: Driving Faster Answers in Clinical Trials.
December 18, 2025
Richmond Pharmacology is proud to announce the publication of an editorial by Elizabeth Romano, Director of Communications and Participant Engagement, in the Winter 2025 issue of the Journal for Clinical Studies.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
